A day after EU Health Minister Harsh Vardhan told Parliament that a Covid-19 vaccine is likely to be obtained until early next year, the Ministry of Health detailed on Friday the ongoing trials. About 30 vaccines are being developed Covid-19. se at a very complex stage, the ministry said.
Read also: Covid-19 Vaccine: These Seven Indian Companies Are Licensed to Make Vaccines
Here are the details
Bharat Biotech: An inactivated total virion candidate vaccine was developed for SARS-CoV-2 through Bharat Biotech International Ltd, the isolated virus (NIV-2020-770) provided through the ICMR-National Institute of Virology Safety and tolerability studies in small animals such as rats, mice and rabbits.
Results: Phase 1 trials and parallel studies of rhesus hamsters and macaques have been completed.
The trial revealed the fair protection of the candidate vaccine. Immunogenicity tests are underway, he said.
Phase 2 trials are underway
Cadilla Healthcare:
A DNA vaccine has been developed. Preclinical toxicity studies have been conducted in mice, rats, rabbits and guinea pigs. “The vaccine was found to be safe and immunogenic,” he said.
Results: Phase 1 clinical trials are complete. The trial revealed the protection of the candidate vaccine. Immunogenicity tests are ongoing, the ministry said.
Phase 2 trials are underway
Indian Serum Institute
IBS and ICMR have come together for the clinical progression of two vaccines.
The Oxford vaccine is found in phase 3 trials in Brazil. Phase 2 and 3 transition studies were introduced through ICMR at 14 staging sites, the ministry said.
ICMR and IBS have been associated for the clinical progression of a “nanoparticle adjuvant vaccine subunit glycoprotein” developed through Novavax in the United States. “The trial will be presented in October, after the IRS vaccine is manufactured,” the ministry said. Said.
“item. title”